Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Top Story
Validation
Immunovia announces positive results for next-gen pancreatic cancer test
Diagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.
Featured
Collaboration
Vertex to pay $25M upfront to scale cell manufacturing technology
Financial Results
Bristol Myers Squibb to reduce workforce in restructuring plan
Latest News
U.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuit
April 24, 2024
Scout secures CARB-X grant to advance diagnostic test development
April 22, 2024
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Quest adds new biomarker test to Alzheimer's portfolio
April 23, 2024
Business Insights
Collaboration
Vertex to pay $25M upfront to scale cell manufacturing technology
Financial Results
Bristol Myers Squibb to reduce workforce in restructuring plan
Lawsuit
U.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuit
Lawsuit
Bio-Techne files EU patent infringement suit against Molecular Instruments
Diagnostic Technologies
Sequencing
Mission Bio launches new features for Tapestri platform
Gene silencing and gene editing
Engineered Cas clears barrier to antiviral CRISPR therapies
Artificial Intelligence
AI-powered endoscope doubles detection of high-risk esophageal lesions
Diagnostic Technologies
Veracyte to share bundle of genomic classifier studies at AUA 2024
Diseases
Point-of-Care Testing
Scout secures CARB-X grant to advance diagnostic test development
Alzheimer's
Quest adds new biomarker test to Alzheimer's portfolio
Neurodegenerative Disease
Target ALS launches new data portal for research
Artificial Intelligence
AI-powered endoscope doubles detection of high-risk esophageal lesions
More from LabPulse.com
Bio-Techne files EU patent infringement suit against Molecular Instruments
By
LabPulse.com staff writers
Life sciences company Bio-Techne has filed a lawsuit against Molecular Instruments in the pan-European Unified Patent Court, alleging patent infringement of its RNAscope in situ hybridization technology.
April 23, 2024
Target ALS launches new data portal for research
By
Matt Limb
A nonprofit medical research foundation has launched a data portal designed to help spur scientific breakthroughs for the disease amyotrophic lateral sclerosis (ALS).
April 23, 2024
Ipsen, Skyhawk to collaborate on drug discovery for rare neurological disorders
By
LabPulse.com staff writers
Biopharmaceutical company Ipsen and clinical-stage biopharmaceutical firm Skyhawk have signed an exclusive collaboration to discover and develop small-molecule therapeutics targeting RNA to treat rare neurological disorders.
April 22, 2024
Engineered Cas clears barrier to antiviral CRISPR therapies
By
Nick Paul Taylor
Researchers have engineered a Cas enzyme to enhance activity against RNA viruses, resulting in a system that completely blocked the replication of various SARS-CoV-2 strains.
April 19, 2024
AI-powered endoscope doubles detection of high-risk esophageal lesions
By
Nick Paul Taylor
Deep learning has doubled the detection of high-risk lesions during routine endoscopies in a clinical trial of more than 3,000 patients in China.
April 17, 2024
Fujifilm Diosynth Biotechnologies confirms layoffs
By
LabPulse.com staff writers
Fujifilm Diosynth Biotechnologies confirmed a restructure that will result in the layoff of 240 employees.
April 19, 2024
Bruker to acquire NanoString for $392.6M
By
LabPulse.com staff writers
NanoString has reached an agreement with Bruker in which Bruker will purchase substantially all of NanoString's assets for approximately $392.6 million in cash, as well as assume certain NanoString liabilities.
April 18, 2024
DermTech receives delisting warning from Nasdaq
By
LabPulse.com staff writers
Melanoma diagnostics company DermTech announced that it has received a delisting warning from Nasdaq.
April 17, 2024
Veracyte to share bundle of genomic classifier studies at AUA 2024
By
LabPulse.com staff writers
Veracyte has announced that the American Urological Association's May meeting will feature nine sessions related to evaluations of its prostate cancer and bladder cancer genomic tests.
April 16, 2024
Nightingale Health to open U.S. lab, collaborate with Englander Institute at Weill Cornell
By
LabPulse.com staff writers
Preventive healthcare company Nightingale Health will open a laboratory in the U.S. In addition, the Englander Institute for Precision Medicine at Weill Cornell Medicine has signed on as its first customer.
April 17, 2024
Co-Diagnostics opens manufacturing facility in Utah
By
LabPulse.com staff writers
Molecular diagnostics firm Co-Diagnostics has opened a new manufacturing facility in South Salt Lake, UT, holding a ribbon-cutting event to inaugurate the facility on April 11.
April 16, 2024
Babson adds hand-warming to blood testing mini-draws in Texas pharmacies
By
LabPulse.com staff writers
Austin, TX-based Babson Diagnostics said it has received positive feedback for its hand-warmer, which is used as part of a finger-stick blood sample collection device in retail pharmacies.
April 16, 2024